SAMH
Shanda Asset Management Holdings Portfolio holdings
AUM
$1.84B
This Quarter Return
+0.13%
1 Year Return
+17.66%
3 Year Return
+105.04%
5 Year Return
+163.25%
10 Year Return
+23.03%
AUM
$528M
AUM Growth
+$528M
(-13%)
Cap. Flow
-$1.34B
Cap. Flow
% of AUM
-252.92%
Top 10 Holdings %
Top 10 Hldgs %
97.14%
Holding
52
New
–
Increased
3
Reduced
3
Closed
19
Top Buys
| 1 |
Hercules Capital
HTGC
|
$14.2M |
| 2 |
Upwork
UPWK
|
$1.63M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$1.08M |
Top Sells
| 1 |
LendingClub
LC
|
$1.28B |
| 2 |
CLDR
Cloudera, Inc.
CLDR
|
$13.9M |
| 3 |
Blackstone
BX
|
$9.14M |
| 4 |
United Rentals
URI
|
$7.75M |
| 5 |
KKR & Co
KKR
|
$6.82M |
Sector Composition
| 1 | Financials | 74.82% |
| 2 | Healthcare | 17.25% |
| 3 | Communication Services | 5.72% |
| 4 | Consumer Discretionary | 1.44% |
| 5 | Technology | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
LendingClub
LC
$1.97B
| $321M | 59.88% | 19,562,881 -78,251,524 | -80% | -$1.28B |
|
2
Community Health Systems
CYH
$387M
| $73.4M | 13.7% | 27,484,473 | – | – |
|
|
3
Hercules Capital
HTGC
$3.55B
| $44.9M | 8.39% | 3,505,755 +1,108,289 | +46% | +$14.2M |
|
|
4
Alphabet (Google) Class A
GOOGL
$2.57T
| $28.2M | 5.25% | 26,000 +1,000 | +4% | +$1.08M |
|
|
5
KKR & Co
KKR
$124B
| $27.3M | 5.09% | 1,080,000 -270,000 | -20% | -$6.82M |
|
6
Amazon
AMZN
$2.44T
| $7.58M | 1.41% | 4,000 | – | – |
|
7
Alarm.com
ALRM
$2.93B
| $3.21M | 0.6% | 60,000 | – | – |
|
8
CRISPR Therapeutics
CRSP
$4.71B
| $2.74M | 0.51% | 58,158 | – | – |
|
9
Editas Medicine
EDIT
$231M
| $2.56M | 0.48% | 103,579 | – | – |
|
|
10
Upwork
UPWK
$2.04B
| $2.03M | 0.38% | 126,160 +101,160 | +405% | +$1.63M |
|
11
Ares Capital
ARCC
$15.8B
| $1.85M | 0.34% | 103,030 | – | – |
|
12
Medpace
MEDP
$13.4B
| $1.76M | 0.33% | 26,882 | – | – |
|
13
IQVIA
IQV
$32.4B
| $1.48M | 0.28% | 9,224 | – | – |
|
14
PTC Therapeutics
PTCT
$3.92B
| $1.37M | 0.25% | 30,332 | – | – |
|
15
Sangamo Therapeutics
SGMO
$157M
| $1.23M | 0.23% | 114,410 | – | – |
|
|
TVRD
16
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $1.18M | 0.22% | 54,984 | – | – |
|
17
Neurocrine Biosciences
NBIX
$13.8B
| $844K | 0.16% | 10,000 | – | – |
|
18
Intellia Therapeutics
NTLA
$1.22B
| $797K | 0.15% | 48,657 | – | – |
|
19
Vanda Pharmaceuticals
VNDA
$279M
| $631K | 0.12% | 44,787 | – | – |
|
20
Axsome Therapeutics
AXSM
$6.05B
| $514K | 0.1% | 19,958 | – | – |
|
|
PRAH
21
DELISTED
PRA Health Sciences, Inc.
PRAH
| $494K | 0.09% | 4,980 | – | – |
|
|
ZGNX
22
DELISTED
Zogenix, Inc.
ZGNX
| $478K | 0.09% | 10,000 | – | – |
|
|
ITCI
23
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $458K | 0.09% | 35,278 | – | – |
|
24
Labcorp
LH
$23.1B
| $401K | 0.07% | 2,318 | – | – |
|
25
Icon
ICLR
$13.8B
| $385K | 0.07% | 2,499 | – | – |
|